Prot #CA180406: Open-Label Single Arm Phase 2 Study Evaluating Dasatinib Therapy Discontinuation In Patients With Chronic Phase Chronic Myeloid Leukemia (CP-CML) With Stable Complete Molecular Response (CMR) DASFREE

Project: Research project

Project Details

StatusFinished
Effective start/end date3/10/14 → 3/10/17

Funding

  • ICON Clinical Research, LLC (Prot #CA180406 // Prot #CA180406)
  • Bristol-Myers Squibb Company (Prot #CA180406 // Prot #CA180406)